000 01575 a2200457 4500
005 20250516031354.0
264 0 _c20111003
008 201110s 0 0 eng d
022 _a1559-131X
024 7 _a10.1007/s12032-010-9422-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEissa, Sanaa
245 0 0 _aThe clinical relevance of urine-based markers for diagnosis of bladder cancer.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_cJun 2011
300 _a513-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xurine
650 0 4 _aCarcinoma, Transitional Cell
_xdiagnosis
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aFibronectins
_xurine
650 0 4 _aHumans
650 0 4 _aKeratin-20
_xurine
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aROC Curve
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSensitivity and Specificity
650 0 4 _aTelomerase
_xurine
650 0 4 _aUrinary Bladder Neoplasms
_xdiagnosis
700 1 _aSwellam, Menha
700 1 _aAmin, Amr
700 1 _aBalbaa, Mohamed E
700 1 _aYacout, Galila Ahmed
700 1 _aEl-Zayat, Tarek Mostafa
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 28
_gno. 2
_gp. 513-8
856 4 0 _uhttps://doi.org/10.1007/s12032-010-9422-6
_zAvailable from publisher's website
999 _c20707331
_d20707331